Moderna is testing potential vaccines against monkeypox in pre-clinical trials as the disease spreads in the United States and Europe.
The World Health Organization said on Tuesday:
There 131 confirmed cases and 106 further alleged cases since the first reported on May 7 outside the countries where it commonly spreads.
Moderna did not proximately react to a request for more particulars on the monkeypox vaccines.
According to the U.S. Centers for Disease Control and Prevention government was in the procedure of liberating doses of a smallpox vaccine Jynneos, made by Bavarian Nordic A/S, for use in monkeypox cases.
HOW RISKY IS IT?
The risk to the general public is low at this time, a U.S. public health official told journalists at a briefing on Friday.
It is a virus that can cause symptoms including fever, and aches and presents with a distinctive bumpy rash.
It is related to smallpox, but is usually slighter, predominantly the West African straining of the virus that identified in a U.S. case, which has a casualty rate of around 1%.
Most people fully recover in two to four weeks, the official said.